The contribution of specific follicle populations to dimeric inhibin production and inhibin subunit mRNA expression by the rat ovary has been investigated in two model systems, granulosa cells isolated from 25-day-old diethylstilboestrol (DES)-treated rats and post-natal rat ovaries, dispersed in culture or whole ovaries, using specific two-site immunoassays and 'real time' PCR. Media from FSH-stimulated granulosa cell cultures fractionated by gel filtration and RP-high performance liquid chromatography revealed two predominant peaks of subunit activity which were attributed to subunit and 31 k dimeric inhibin-A. The corresponding inhibin-B levels were low. FSH stimulation did not alter the ratio of inhibin-A: subunit produced by granulosa cells. All three inhibin subunit mRNAs were expressed by granulosa cells, with eight-fold more subunit mRNA relative to either of the subunits. Administration of DES to immature rats prior to the isolation of granulosa cells from the ovary led to A and B mRNA expression being down-regulated in the absence of any significant change in subunit expression by the granulosa cells. Inhibin-A, -B and -subunit were produced by basal and stimulated cultures of ovarian cells prepared from 4-, 8-and 12-day-old rats, indicating that primary, preantral and antral follicles contribute to total inhibin production. Consistent with these results, follicles within these ovaries expressed all three inhibin subunit mRNAs, with maximal expression observed in the ovaries of 8-day-old rats. The appearance of antral follicles in the ovary at day 12 led to a decline in the mRNA levels of each of the subunits but was most evident for the subunits. There was a profound influence of secondary preantral follicles on dimeric inhibin-A production, with FSH stimulation increasing inhibin-A relative to subunit levels in cultures of ovarian cells prepared from 8-day-old rats. Thus, preantral follicles exposed to FSH contribute significantly to A subunit production by the ovary. In contrast, primary and preantral follicles did not produce inhibin-B in response to FSH stimulation. Transforming growth factor-(TGF-) enhanced, in a time-dependent manner, the production of the inhibin forms by ovarian cells in culture, although inhibin-B production was not responsive until day 8. The simultaneous treatment of ovarian cell cultures with FSH and TGF-elicited the greatest increases in production of all the inhibin forms.
Introduction
Inhibin, a heterodimeric molecule composed of an and subunit linked by disulphide bonds, is produced by granulosa cells of the ovary and feeds back on the pituitary to negatively regulate follicle-stimulating hormone (FSH) secretion (for reviews see McLachlan et al. 1987 , Burger 1993 . Inhibin is also thought to play local regulatory roles in the ovary since it has been shown to directly modulate thecal cell androgen synthesis (Hillier et al. 1991) and oestrogen production (Smyth et al. 1994) , and it has been postulated to promote follicular growth (Woodruff et al. 1990) . Recently, binding sites for inhibin were demonstrated on ovarian cells (Draper et al. 1998) .
Two forms of dimeric inhibin have been identified on the basis of the contributing subunit, either A which gives rise to inhibin-A, or B which gives rise to inhibin-B. It has been shown previously by Northern blot, in situ hybridisation and immunohistochemical analyses (Woodruff et al. 1987 , Meunier et al. 1988 , Jih et al. 1993 , Drummond et al. 1996 ) that mRNA and protein, respectively, for the inhibin subunits ( , A and B ) are produced by ovarian granulosa cells, and inhibin immunoactivity and bioactivity have been measured in ovarian extracts and conditioned media collected from granulosa cell and ovarian cell cultures (Erickson & Hsueh 1978 , Bicsak et al. 1986 , Suzuki et al. 1987 , Robertson et al. 1988 , Drummond et al. 1996 . It is still unclear, however, which of the biologically active forms produced by the ovary are responsible for the actions of inhibin and whether the production of the inhibin forms varies according to the stage of ovarian development or follicle type. Studies of human plasma and follicular fluid indicate that inhibin-B is likely to be the predominant form in the early follicular phase of the menstrual cycle when small antral follicles are recruited, but that inhibin-B levels subside during the late follicular phase as inhibin-A levels ascend with the appearance of the dominant follicle and peak after ovulation . Follicular fluid aspirated from early follicular-phase follicles contains inhibin-B at concentrations up to 200-fold higher than inhibin-A , Magoffin & Jakimiuk 1997 . In cycling female rats, serum profiles of inhibin-A and -B are similar (Woodruff et al. 1996) , although inhibin-B levels were higher than inhibin-A during metoestrus which may reflect changes in the follicle population and recruitment of new follicles into the next cycle.
Our interest in the ovary has focused on the early stages of folliculogenesis and, in particular, the period of development when follicle populations are established for the first time. We have defined these stages in the post-natal rat ovary and characterised the specific follicle populations present 4, 8 and 12 days after birth (Drummond et al. 1996) . Follicle populations from primordial and primary (day 4) to preantral (day 8) to antral (day 12) appear in the ovary in a sequential manner so that it is possible to examine, in isolation, specific follicle populations. Thus, this model provides a unique opportunity to examine the role of primordial and primary, preantral/secondary and antral follicles in inhibin production.
In recent years, inhibin has been measured in biological fluids by either in vitro bioassay or radioimmunoassay (RIA). The lack of assay specificity and the detection of immunoactivity in samples which conferred little or no biological activity has impeded the elucidation of roles for the individual inhibin forms in the regulation of ovarian function and FSH secretion. With the availability of 'two-site' assays for the specific inhibin forms (Groome 1991 , Robertson et al. 1997 it is now possible to begin addressing these issues.
We previously examined the role of activin in the post-natal ovary and demonstrated a facilitatory action of activin in mediating the responsiveness of granulosa cells to FSH in terms of progesterone and inhibin production (Drummond et al. 1996) . Apart from activin, other members of the transforming growth factor-(TGF-) family of peptides, notably TGF-, have been shown to locally regulate aspects of ovarian function (Knecht et al. 1987 , Zhang et al. 1988 , Dunkel et al. 1994 , Lanuza et al. 1999 . TGF-stimulated inhibin production by isolated granulosa cells (Zhang et al. 1988 , Lanuza et al. 1999 , with the suggestion that inhibin-B may be stimulated in preference to inhibin-A (Lanuza et al. 1999) . The potential for TGF-and activin to initiate different responses within ovaries, depending on the age of the donor animal and follicular status or, alternatively, issues related to redundancy if similar roles exist, remain to be clarified. These studies were undertaken to measure the hormonal (TGF-, FSH) and temporal regulation of inhibin-A, inhibin-B and inhibinsubunit produced by post-natal rat ovarian cells. In addition, the inhibin forms produced by the immature ovary were investigated using granulosa cell-conditioned media prepared from diethylstilboestrol (DES)-treated rats. Inhibin-B and inhibin-subunit were measured using established assays , Robertson et al. 1997 ) whereas a new, previously unpublished immunofluorometric assay (IFMA) was used to measure inhibin-A.
Since we cannot directly compare the levels of inhibin-A, -B and -subunit due to the absence of a suitable rat standard, we decided to quantitate the steadystate mRNA levels of the inhibin subunits in the ovary during post-natal development and in isolated granulosa cell preparations using novel 'real time' polymerase chain reaction (PCR) technology. Changes in the expression of the inhibin subunit mRNAs by specific follicle populations and the impact of in vivo oestrogen treatment prior to granulosa cell isolation in a well-characterised immature rat model were investigated.
Materials and Methods

Hormones and reagents
Rat FSH (rFSH-I8) was obtained from the National Hormone and Pituitary Distribution Program and the NIADDK, NIH (Baltimore, MD, USA). Human recombinant-activin A was provided by Dr A Mason (Biota, Clayton, Victoria, Australia). Natural human TGF-was purchased from Genzyme (Cambridge, MA, USA). Human recombinant inhibin-B was provided by Dr J Mather (Genentech Inc., South San Francisco, CA, USA). Human recombinant inhibin-A was provided by Biotech Australia (Roseville, NSW, Australia).
Animals
Sprague-Dawley rats were obtained from Central Animal Services, Monash University (Melbourne, Australia). The project was approved by the institutional Animal Experimentation and Ethics Committee as conforming to the guidelines of the National Health and Medical Research Council of Australia.
Post-natal ovarian cell cultures
Dispersed ovarian cell suspensions were prepared by enzymatic digestion (Drummond et al. 1996) from 4-, 8-and 12-day-old rats. Briefly, cells (1·5 10 5 /well) were incubated in quadruplicate in serum-free McCoy's 5C, C McCoys SA (Trace Biosciences, Sydney, Australia) containing transferin and glutamine alone or with FSH (20 ng/ml), TGF-(10 ng/ml) or a combination of FSH plus TGF-, at the doses indicated for single treatments alone. The doses of TGF-and FSH were chosen based on their ability to stimulate immunoactive inhibin production (A E Drummond, M Dyson & J K Findley 1996, unpublished observations). To investigate the time-course of inhibin production, cells were incubated for 6, 12, 24, 48 or 72 h, after which the conditioned media were collected and stored frozen until required for assay. Other ovarian cell cultures were incubated in McCoy's 5C with treatments for 48 h at 37 C. Individual wells of cultures were pooled (n=10-15 wells) for characterisation of inhibin immunoactivity by the respective assays. The pools were frozen until required for assay. Under all culture conditions, cell numbers were unchanged, as determined by a neutral red proliferation assay (Lowik et al. 1993) .
Granulosa cell cultures
Granulosa cell cultures were prepared from 25-day-old, DES-treated rats as previously described (Xiao et al. 1990) . Briefly, cells (2 10 5 /well) were incubated for 48 h at 37 C in McCoy's 5C in the presence or absence of FSH (20 ng/ml). Two conditioned media pools, a basal control pool (CM) and an FSH-stimulated pool (CM-FSH) were prepared, and used in either fractionation studies or as quality controls in the inhibin assays. A marked decrease in the levels of the inhibin forms which could be measured by immunoassay was noted with time, even though the pools were aliquoted and did not undergo repeated cycles of freeze-thawing. This loss of activity was prevented by the following treatment: an aliquot of CM-FSH was concentrated (Centricon; Amicon Inc., Beverly, MA, USA) and then gel filtered (PD10 column; Pharmacia, Uppsala, Sweden) to TSA (50 mM Tris-HCl/0·9% NaCl/0·05% NaN 3 , pH 7·5)/0·5% bovine serum albumin (BSA). Aliquots were snap frozen and stored at 20 C until required.
Gel filtration and reverse phase-high performance liquid chromatography (RP-HPLC)
Conditioned media (CM-FSH) was fractionated by gel filtration and RP-HPLC. Gel filtration of CM-FSH was undertaken using a Superdex HR 75 column (Pharmacia) in 20 mM Tris/10% acetonitrile/0·2 M NaCl/0·05% BSA, pH 7·5. The flow rate was 0·4 ml/min and 0·2 ml fractions were collected. The fractions were stored frozen until required for assay. Fractionation of CM-FSH by RP-HPLC was undertaken using a C4 column (Brownlee; Applied Biosystems, San Jose, CA, USA) connected to a Waters HPLC system (Milford, MA, USA). The column was eluted with a linear gradient of 0-50% acetonitrile in 0·1% trifluoroacetic acid. The flow rate was 1 ml/min and 0·5 ml fractions were collected. The RP-HPLC fractions were freeze-dried and reconstituted prior to assay in TSA/0·5% BSA.
IFMA for dimeric inhibin-A and inhibin-subunit
Buffers and reagents The subunit antibody used as capture antibody in these assays was raised in sheep against a human recombinant inhibin-C subunit fusion protein (Forage et al. 1987 , Robertson et al. 1997 . A caprylic acid IgG cut of sheep antiserum (no. 41) was immunopurified on a column (Reactigel; Pierce, Rockford, IL, USA) coupled to a bovine inhibin-C subunit fusion protein (provided by Biotech Australia, Roseville, NSW, Australia). The no. 41 antiserum was chosen as capture antibody for the subunit because of its high affinity for rat inhibins. A monoclonal antibody to the A subunit (2B10) was raised in mice to a A subunit fusion protein (provided by Biotech Australia) and screened with human recombinant 31 k inhibin-A. The 2B10 antisera was of an IgG 2a, light chains isotype. The antiserum was purified on a protein G column. The 2B10 antibody binds human A subunit, human activin-A and human inhibin-A but does not bind human C subunit, human N subunit or human inhibin-B. Immunopurified 41 C and purified 2B10 antisera were biotinylated (Robertson et al. 1997) for use as labelled second antibodies in the appropriate assays. Triton (1%) was added to the TSA assay buffer to reduce the potential for cross-reaction in the inhibin-A assay with activin. For the subunit assay, 0·1% ovine IgG was added to the TSA buffer to prevent heterophilic antibody binding.
Standard preparations
Since rat inhibin standards are not available, a human recombinant 31 k inhibin preparation supplied by Biotech Australia (Sydney, Australia) was used in the inhibin-A and inhibin-subunit assays. Pools of conditioned media collected from rat granulosa cell cultures were tested in the assays for parallelism and linearity to the human standard. The potency of this preparation was calibrated in terms of the WHO human 31 k inhibin-A standard 91/624. Relative to the inhibin-A 91/624 preparation, the 31 k human inhibin preparation used as assay standard was 1·1 and 1·2 times more potent in the inhibin-A and subunit assays respectively.
Assay protocol
The assay protocol was similar to that described by Robertson et al. (1997 Robertson et al. ( , 1999 . Briefly, the capture antibody, 41 C (1 µg/200 µl), was absorbed to wells of 96-well plates (Maxisorp; Nunc, Roskilde, Denmark), during an overnight incubation at 37 C. The plates were washed twice with wash buffer (5 mM Tris/ 0·9% NaCl/0·05% Tween 20/0·05% merthiolate, pH 7·75) and then blocked with 1% BSA in 10 mM phosphate-buffered saline/0·9% NaCl/0·1% NaN 3 , for a minimum of 2 h at room temperature (RT). The plates were aspirated and stored at 4 C in a humidified atmosphere until required. Samples and standards were diluted in assay buffer or culture media and 100 µl transferred to wells. Media or assay buffer (100 µl/well) was added to bring the total volume to 200 µl/well. The plate was then shaken for a minimum of 2 h at RT after which it was washed three times, and biotinylated antibody, 2B10 (50 ng/well) for inhibin-A or 41 C (100 ng/well) for subunit, was added to each well and the plate shaken for 2 h at RT. The plate was then washed three times and the label, Europium-streptavidin (50 ng/200 µl; Wallac, Turku, Finland) diluted in assay buffer, was added to each well and the plate shaken for 30 min. After thorough washing, 200 µl enhancement solution was added to each well and the plates were shaken for 5 min, after which the fluorescence was measured using time-resolved fluorometry (1234 Fluorometer; Wallac).
The inter-and intra-assay variations for the inhibin-A IFMA were 12% and 6% (n=5) respectively, and the sensitivity of the assay was 20 pg/ml. The inter-and intra-assay variations for the subunit IFMA were 15% and 5·5% (n=3) respectively, and the sensitivity of the assay was 100 pg/ml.
Inhibin RIA
Inhibin forms containing the C subunit were also measured using the Monash double antibody RIA described previously (Robertson et al. 1988) . The antiserum (no. 1989) was raised against 31 k bovine inhibin and the standard used was a rat ovarian extract of arbitrary unitage (Robertson et al. 1988) . The inter-and intra-assay variations were 11·5% and <10% respectively, and the sensitivity of the assay was 0·4 U/ml.
Inhibin-B enzyme-linked immunosorbent assay (ELISA)
The ELISA method of Groome et al. (1996) was employed. Prior to assay, the samples and standards were boiled in 2% SDS and treated with hydrogen peroxide, as recommended. A rat ovarian extract (ROVE; Robertson et al. 1988 ) and a partially purified inhibin-B preparation isolated from human follicular fluid (Groome standard) were used as standards. The Groome standard was used to measure inhibin-B in fractions collected by gel filtration and HPLC. The sensitivity of the assay was 20 pg/ml (Groome standard). These studies indicated that the human standard preparation was not appropriate for the measurement of rat inhibin-B due to an unacceptably high interassay variation (32%, n=10). In order to reduce this variation, the human and ROVE standard preparations were compared in three successive parallel line assays. The potency of the ROVE preparation in terms of the Groome standard was calculated at 1·16 0·24 pg/ml (n=3), with an interassay variation of 36% (n=3). Parallelism was observed between preparations based on the absence of significant differences in the slope values of the doseresponse lines. The ROVE standard was used in subsequent assays to measure inhibin-B because the inter-and intra-assay variations were acceptable (10% n=3). The sensitivity of the assay was 30 U/ml (ROVE standard).
RNA purification and reverse transcription
RNA was purified using the method of Chomczynski & Sacchi (1987) from ovaries of 4-, 8-, 12-and 22-day-old rats (standard and quality control pools) and granulosa cells isolated from the ovaries of 25-day-old rats which were either untreated or treated with DES for 4 days prior to excision of the ovaries (Xiao et al. 1990 ). The number of ovaries/pool ranged from 24 to 40 for post-natal animals (4-to 12 day-old rats) and 4 to 8 for immature animals (22-to 25-day-old rats). Two micrograms of each RNA/tube were reverse transcribed using Moloney murine leukaemia virus (MMLV) (Expand; Roche, Mannheim, Germany) reverse transcriptase and oligo dT 15 (Drummond et al. 1999) .
'Real time' PCR analysis of ovarian inhibin subunit mRNAs
Inhibin subunit mRNA expression was analysed using the Roche LightCycler (Roche). The instrument is a rapid thermal cycler that monitors fluorimetrically, in real time, the formation of PCR products with fluorescent dyes, in this instance SYBR Green I. In its unbound state, SYBR Green I dye has relatively low fluorescence but when bound to double-stranded DNA it fluoresces strongly; thus, as the amount of DNA or PCR product increases, the amount of fluorescence from the dye increases proportionally. The log-linear portion of the amplification curve is identified with the threshold or crossing point (represented in cycle number) defined as the intersection of the best-fit line through the log-linear region and the noise band. In these studies, a rat ovarian cDNA preparation of arbitrary unitage was employed as the assay standard. The levels of expression of each mRNA and their estimated crossing points in each sample were determined relative to the standard preparation using the LightCycler computer software. A ratio of specific mRNA/GAPDH amplification was then calculated. Reagents for reverse transcription and LightCycler PCR were purchased from Roche Biochemicals.
For PCR, 2 µl each of the standard cDNA pool diluted 1:5, 1:100 and 1:2000 (arbitrarily designated 1·0, 0·05 and 0·0025 respectively), the quality control cDNA pool diluted 1:25 and the sample cDNAs diluted 1:15-1:25 in sterile water were added to individual capillaries. NTPs, Taq enzyme, reaction buffer and SYBR Green I dye were supplied in the LightCycler DNA Master SYBR Green I kit, of which 2 µl/capillary was added. Primer concentrations of 17·5 pmol (GAPDH) and 25 pmol (inhibin subunits) were added to each capillary. The primer specific nucleotide locations and sequences are shown in Table 1 . Magnesium concentrations, annealing temperatures and extension times for the individual primer sets are shown in Table 2 . The capillary volume was made up to 20 µl with sterile water. Forty cycles of PCR were programmed to ensure that the threshold crossing point (cycle number) was attained. Fluorescence emission was monitored continuously during cycling. At the completion of cycling, melting curve analysis was carried out to establish the specificity of the DNA products produced. In the initial optimisation stages for each primer set, agarose gel electrophoresis, as previously described (Drummond et al. 1999) , was also employed to establish the integrity of the PCR reaction and product size.
In most instances, individual pools for each age group or treatment with each primer set were performed in a single PCR experiment. The intra-assay variation was never more than 5% (n=7) regardless of the primer set. The nature of LightCycler PCR diminishes issues such as assay sensitivity and, at the concentrations (dilutions) of standard and sample utilised in these studies, the sensitivity threshold (picograms) was never approached.
Statistical analysis
The data from ovarian cell cultures are presented as the mean ... of determinations from three or four replicate wells (unless specified) within each treatment group, from a single experiment (unless otherwise stated). Each experiment was repeated at least three times. The mRNA expression data are represented as the mean ... of at least three individual pools of RNA for each age or treatment group, analysed by real time PCR. Statistical significance was determined by analysis of variance after log transformation of the data and calculation of least significant differences. P values of <0·05 were regarded as statistically significant. To validate the assays for measurement of rat inhibins, sample and standard dilution curves were assessed by parallel-line bioassay statistics (after log transformation of the data), in order to obtain potency estimates and establish the linearity, parallelism and precision of the dose-response curves (Finney 1964) .
Results
Characterisation of the assays (inhibin-A, subunit IFMAs and inhibin-B ELISA)
Pools of conditioned media collected from basal (CM) and FSH-stimulated (CM-FSH) rat granulosa cell cultures diluted linearly and in parallel to the human 31 k inhibin preparation used as standard in the subunit and inhibin-A IFMAs (Fig. 1) . In both CM and CM-FSH pools there was approximately 3·5-fold more subunit than inhibin-A. The relative levels of inhibin-A: subunit did not change with FSH stimulation (Table 3 ). In the inhibin-A IFMA, no significant cross-reaction was observed with human activin-A (<0·005%), human inhibin-B (<0·01%) or human TGF-(0·01%). Similarly, in the subunit IFMA, no significant cross-reaction was observed with human activin-A (0·008%) or human TGF-(0·027%), but human inhibin-B cross-reactivity was estimated at 93%. Groome inhibin-B standard and ROVE diluted linearly and in parallel to each other in the inhibin-B ELISA (Fig. 1) .
Fractionation of granulosa cell-conditioned media
Two peaks of subunit activity were observed following gel filtration of CM-FSH (Fig. 2) . The major peak coincided with inhibin-A activity from both the conditioned media pool (CM-FSH) and a media preparation spiked with the 31 k human inhibin-A standard. The smaller peak most likely represents higher molecular weight forms of the free subunit. Regression analysis of the subunit and inhibin-A IFMA profiles for the CM-FSH pool revealed a close correlation (r=0·98). Low levels of inhibin-B (<125 pg/ml) were measured across the profile although no distinct elution pattern was observed. To differentiate between subunit and inhibin-A, CM-FSH was subject to RP-HPLC (Fig. 3) . Two broad peaks of subunit activity were observed. The first peak correlated with inhibin-A activity and represented 52% of total subunit activity. It is worth noting that both the inhibin-A and subunit IFMAs measured similar levels of activity in these fractions. The second peak of activity corresponds to other subunit-containing inhibin forms. Low levels of inhibin-B (<150 pg/ml) were measured across a broad area of the profile.
Time-course of inhibin production by dispersed ovarian cell cultures
The time-course of inhibin production by post-natal ovarian cells prepared from 8-day-old rats, under basal or stimulated conditions, as measured by the Monash RIA, inhibin-A and subunit IFMAs is shown in Fig. 4 . Low levels of the inhibin forms were measured at 6 and 12 h, under all treatment conditions. Thereafter, inhibin production by these cultures increased for at least 72 h. The FSH plus TGF-treatment was most effective at stimulating inhibin-A and subunit production. Similar time-courses were established for ovarian cell cultures prepared from 4-and 12-day-old rats (data not shown). 
The effect of TGF-, FSH and combined treatments on inhibin-A, subunit and inhibin-B production by ovarian cell cultures
Inhibin-A and subunit production by dispersed ovarian cell cultures (day-4, -8 and -12 cultures) were stimulated by FSH, TGF-and TGF-plus FSH (Fig. 5 ). Basal and stimulated levels of inhibin-A and subunit increased with the age of the donor rat. Inhibin-A, but not subunit, production by FSH-stimulated day-4 cells was enhanced by TGF-. In cultures of ovarian cells prepared from 8-and 12-day-old rats, TGF-enhanced FSHstimulated inhibin-A and subunit production (Fig. 5) .
Inhibin-B was detected in conditioned medium of all basal cultures of day-4, -8 and -12 ovarian cells (Fig. 5) . Inhibin-B production by day-4 ovarian cells was not responsive to FSH or TGF-alone but, in combination, the levels were enhanced approximately 2·5-fold (Fig. 5) . Day-8 ovarian cell inhibin-B production remained unresponsive to FSH stimulation although these cells increased their output in response to TGF-. In day-12 ovarian cell cultures the response to TGF-alone was greater than the response to FSH alone (Fig. 5) . The TGF-/FSH treatment was the most effective at stimulating inhibin-B production by day-8 and -12 ovarian cells.
To gauge the impact of follicle populations on inhibin-A and subunit production, the data in Fig. 5 have been replotted as a function of age (Fig. 6) . The ratios confirmed the data (Figs 2 and 3 ) that subunit is produced in excess of inhibin-A. Preantral follicles of 8-day-old rat ovaries produced considerably more inhibin-A relative to subunit in response to FSH or TGF-plus FSH, with the ratios similar to those calculated for conditioned media collected from granulosa cell cultures (Fig. 6) . In contrast, TGF-alone produced a ratio similar to that observed in control post-natal rat ovarian cultures. The appearance of antral follicles in 12-day-old rat ovaries resulted in an increase in subunit production relative to inhibin-A, as indicated by a fall in the inhibin-A: subunit ratio.
Expression of inhibin subunit mRNAs by post-natal ovaries
Data generated by LightCycler PCR for the inhibin subunit are represented in Fig. 7 . Figure 7A shows the change in fluorescence of three dilutions of the standard cDNA preparation with increasing cycle number, as a result of amplification of the cDNA. The intersection of the crossing point line, defined after background noise is eliminated from the profile, with the extrapolated loglinear portion of the fluorescence profile is termed a 'crossing point'. The standard curve consists of these crossing points defined in terms of cycle number, plotted against the log concentration of the standard cDNA (Fig. 7B) . The size of the subunit PCR product (306 bp) was confirmed by gel electrophoresis (Fig. 7C ) and melting point analysis gave a melting point (91·4 C) characteristic for this product, with all three dilutions of the standard producing overlapping profiles (Fig. 7D) . Similar profiles were collected for each inhibin subunit (data not shown) so that the level of expression of each mRNA could be calculated. The expression of inhibin , A and B subunit mRNAs was detected in 4-day-old rat ovaries and became maximal in ovaries collected from 8-day-old rats (Fig. 8) . Thereafter, the level of mRNA expression of each inhibin subunit declined significantly with A returning to levels of expression recorded in 4-day-old ovaries, B levels falling below the level of expression found in day-4 ovaries and subunit expression reduced but elevated relative to day-4 levels.
To directly compare the levels of expression of each inhibin subunit mRNA in 4-, 8-and 12-day-old ovaries, threshold crossing points (cycle numbers) were analysed ( Fig. 9 ) and fold changes calculated (Table 4) . On each of the days observed, there was significantly greater expression of inhibin-subunit mRNA in the ovaries, as indicated by the reduced number of PCR cycles to attain the threshold crossing point, relative to A or B (Fig. 9 ) and 16-, 32-and 64-fold increases in expression were calculated at day 4, 8 and 12 respectively (Table 4) . Similar levels of expression of A and B mRNAs at day 4 and 8 were noted, but by day 12 there was two-fold more A subunit mRNA relative to B subunit mRNA ( Fig. 9 and Table 4 ).
Expression of inhibin subunit mRNAs by isolated granulosa cell preparations
The three inhibin subunit mRNAs were present in granulosa cells isolated from ovaries of untreated or DES-treated rats (Fig. 10) . DES treatment for 4 days Figure 5 Inhibin-A, -B and -subunit levels in conditioned media collected from dispersed ovarian cell cultures of 4 (D4)-, 8 (D8)-and 12 (D12)-day-old rats, after various treatments. For inhibin-A and subunit measurements, conditioned media from each treatment group were serially diluted and compared with the human recombinant 31 k inhibin as standard using parallel-line bioassay statistics. Statistical significance was determined from calculated 95% confidence limits, the upper 95% limit being represented as error bars on the figure. Inhibin-B was measured at a single dilution using the ROVE preparation as standard and the data expressed in terms of the Groome inhibin-B standard (pg/ml). Media alone (C), TGF-(10 ng/ml) and FSH (20 ng/ml); combined TGF-and FSH regimens employed doses used for single treatments. Statistical significance is indicated by different letters, P<0·05. The data are representative of three experiments for inhibin-A and subunit, while the inhibin-B data are the mean of three experiments.
prior to granulosa cell isolation significantly reduced the level of expression of both subunit mRNAs by granulosa cells without changing the expression of inhibin subunit mRNA compared with control ( Fig. 10) .
To directly compare the levels of expression of each inhibin subunit mRNA in these granulosa cell preparations, threshold crossing points (cycle numbers) were analysed ( Fig. 11) and fold changes calculated (Table 5 ). In granulosa cell preparations isolated from ovaries of both untreated and DES-treated rats, inhibin subunit mRNA was expressed at significantly greater levels than either of the subunits, as indicated by the reduced number of cycles required to reach the threshold crossing point (Fig. 11) and the calculated eight-fold difference in mRNA expression (Table 5 ). There was no difference in the relative levels of expression of A or B in granulosa cells from DES-treated or control immature rats.
Discussion
The significance of individual follicle populations, in relation to dimeric inhibin and free inhibin subunit The T m for a DNA product is defined as the temperature at which half of the DNA helical structure is lost. For the inhibin-subunit PCR product the T m was estimated to be 91·4 C.
production and inhibin subunit mRNA expression, has been addressed in these studies using the post-natal rat ovary as a model and specific two-site immunoassays and real time PCR respectively. Characteristic populations of follicles are contained within the ovaries of 4-, 8-and 12-day-old rats (Drummond et al. 1996) . Ovaries of 4-day-old rats are composed of primordial and primary (Fig. 3) where a difference of one cycle corresponds to a two-fold change in expression. The level of expression was determined relative to the expression of the B subunit, which was arbitrarily assigned a value of 1 on each of the days.
follicles, whereas day-8 ovaries contain numerous preantral follicles with multiple layers of granulosa cells and day-12 ovaries contain antral follicles, in addition to their complements of primordial and primary follicles. We have previously measured the levels of immunoactive inhibin by the relatively non-specific Monash RIA, in cultures of post-natal ovarian cells stimulated with activin (Drummond et al. 1996 ), but it was not possible at that time to ascertain what proportion of measured inhibin could be attributed to free subunit (and thus biologically inactive inhibin), or dimeric inhibin-A or -B, given that the RIA detected all inhibin forms containing an subunit. In this study, specific two-site assays for inhibin-A, -B and all subunit-containing inhibin forms were employed to investigate the inhibin forms present in post-natal ovarian cell-conditioned media and granulosa cell-conditioned media prepared from DES-treated rats. The regulation and temporal production of the inhibins by post-natal ovarian cells was also assessed. In addition, we estimated the level of expression of each of the inhibin subunit mRNAs by real time PCR. This novel technology offers superior semi-quantitative analysis of gene expression. Real time PCR has a rapid turn-around time for amplification of cDNA (approximately 30 min/run) and does not need procedures such as gel electrophoresis and Southern blots for analysis of PCR products. The technique is highly sensitive and only picogram quantities of (Fig. 5) where a difference of one cycle corresponds to a two-fold change in expression. The level of expression was determined relative to the expression of the B subunit, which was arbitrarily assigned a value of 1 for each treatment.
cDNA are required for amplification. It is also possible to directly compare the levels of expression of individual PCR products by analysing crossing point values and calculating fold changes in relation to cycle numbers, given that a difference of one cycle corresponds to a two-fold change in expression, when PCR is performed in the linear range. All forms of immunoactive inhibin (inhibin-A, -B and -) were detected in medium conditioned by post-natal ovarian cells and granulosa cells prepared from DEStreated rats, which is consistent with the finding that follicle populations, primary through to antral, expressed the inhibin subunit mRNAs (Drummond et al. 1996, this study) . The levels of subunit measured in these conditioned media samples were greater than that which could be accounted for in terms of dimeric inhibin-A or -B, indicating that free inhibin subunit is prominent in the ovary. This observation was confirmed in fractionation of CM-FSH using an HPLC procedure known to separate dimeric inhibin from monomeric inhibin (Risbridger et al. 1989) and by the mRNA analyses which showed that inhibin subunit mRNA was always more abundant than either subunit. It remains unclear as to why an excess of subunit is produced by the rat ovary. A large reservoir of subunit may be necessary to ensure formation of dimeric inhibin, rather than allow dimerisation of the subunits to produce activins. Further studies are required to expand on the kinetics and processing of the inhibin subunits, in combination with measurements of activin. A close correlation of subunit activity with inhibin-A was noted following HPLC fractionation of conditioned media. Inhibin-A activity was largely responsible for the first peak of subunit activity, with the second peak of activity most likely due to free forms of the subunit, given that inhibin-B does not seem to contribute significantly to the subunit content of the conditioned media pool. These data showed that the levels of inhibin-A and subunit could be directly compared, which is perhaps not surprising given that the assays share a common standard and coating antibody. Gel filtration confirmed previously published observations (Bicsak et al. 1988 , LaPolt et al. 1989 that the predominant inhibin forms in FSH-stimulated granulosa cell-conditioned media are 31 k inhibin and molecular weight forms of the subunit greater than 31 k. However, unlike Bicsak et al. (1988) , we were able to detect 31 k inhibin in basal granulosa cell-conditioned media (data not shown). This difference probably reflects the different methodologies employed and their relative sensitivities. Our data suggest that the predominant form of dimeric inhibin produced by cultures of FSHstimulated granulosa cells prepared from DES-treated, 25-day-old rats is inhibin-A. Our results are consistent with Lanuza et al. (1999) who reported that FSHstimulated granulosa cell cultures prepared from DEStreated immature rats produced fivefold more inhibin-A than inhibin-B and basal cultures produced 10-to 15-fold more inhibin-A than inhibin-B. Inhibin-B, while detectable across gel filtration and HPLC profiles, was without any clear elution pattern and did not appear to contribute substantially to total inhibin production by these differentiated granulosa cells. Furthermore, given that the crossreactivity of inhibin-A in the inhibin-B ELISA is estimated at 0·5% , it is quite likely that some of the activity measured in these fractions was due to the presence of inhibin-A and not directly due to inhibin-B.
The actual levels of the inhibin forms reported here may be underestimated as Woodruff et al. (1996) suggest, given that the subunit of the human and rat differ in amino acids 1-32. The degree of underestimation is dependent on the extent to which human and rat inhibins cross-react in the assay. Simply put, rat inhibins are likely to have a reduced affinity for antibody reagents based on the human sequence, which is clearly a problem for laboratories undertaking inhibin measurements in biological fluids of non-human species, since most of the new generation assays employ human assay standards and antibodies directed at the human subunit. It was evident from the high between-assay variation that we calculated for the inhibin-B ELISA that the human standard used in this assay was not appropriate for the measurement of rat inhibin-B in conditioned media. The extensive washing of the plates, which was required to maintain low background, was detrimental to the binding of rat inhibin-B to the human-based antibody reagents. Quite simply, rat samples and the human standard behaved differently under the defined assay conditions, hence our utilization of a rat ovarian extract (ROVE) as standard for the measurements of inhibin-B in conditioned media from post-natal ovarian cell cultures. Nevertheless, the pattern of secretion of inhibin-B by post-natal ovarian cells was reproducible whatever standard was employed. It will, however, require suitable purified rat standard preparations to become available for the absolute levels of all the inhibin forms to be determined.
The capacity of the ovary to produce dimeric inhibin-A, -B and -subunit (IFMA and Monash RIA), in general, increased with age and follicular development. All inhibin forms were detected in basal cultures of dispersed ovarian cells, indicating that even the smallest follicles, most likely primary follicles, are capable of producing inhibin. The results are consistent with our data on the expression of the mRNA and protein for the inhibin , A and B subunits in the ovary during post-natal development (Drummond et al. 1996 , this study). Primordial and primary follicles of 4-day-old ovaries responded differentially to FSH and TGF-in terms of the inhibin forms, with inhibin-A and subunit levels enhanced but inhibin-B levels unchanged from basal. The most dramatic change occurred between days 4 and 8 when notable increases in inhibin levels occurred, particularly in inhibin-A and subunit, indicating that the proliferation of granulosa cells and the appearance of preantral/secondary follicles is a defining point in ovarian inhibin production. Consistent with these results, an increase in the expression of all of the inhibin subunits was observed in the ovaries of 8-day-old rats. Changes in the sensitivity of these follicles to FSH was highlighted by calculation of an inhibin-A: subunit ratio, which showed that more inhibin-A was produced relative to subunit in response to FSH at day 8 than day 4. This finding also implies an increased capacity of preantral follicles to produce A subunits and thus the potential for an increase in activin-A production exists. The appearance of antral follicles in the ovaries of 12-day-old rats signalled a fall in the inhibin-A: subunit ratio which could be attributed to either an increase in subunit production by the ovary or a decline in A subunit production. We noted that subunit mRNA expression declined with the appearance of antral follicles at day 12. It was also interesting to note that preantral follicles did not produce inhibin-B in response to FSH alone but, in combination with TGF-, inhibin-B levels were significantly enhanced. In the absence of calibrated standard preparations we cannot directly compare the levels of inhibin-A and inhibin-B. We have, however, presented data which allow us to hypothesise that both dimeric inhibin forms are produced by the post-natal rat ovary (cell culture data) and, after day 4, are equally responsive to stimulation, but that at some point during development inhibin-A production increases relative to inhibin-B and inhibin-A becomes the predominant form (gel filtration and HPLC data) in the ovary. Our hypothesis is further supported by the decline in expression of B relative to A mRNA, which was observed in the ovaries of 12-day-old rats. The actual levels of TGFand FSH and the presence and concentration of their specific receptors within individual follicles during development will be important for establishing how follicles respond in terms of dimeric inhibin production. Our preliminary studies investigating dimeric inhibin production in response to activin (A E Drummond & J K Findlay, unpublished observations) using the two-site immunoassays described above, indicate that, in combination with FSH, activin stimulated production of the inhibin forms beyond that elicited by the individual factors or the combined regimen of TGF-and FSH, in post-natal ovarian cell cultures. Issues related to redundancy or indeed specific roles for activin and TGF-in the ovary are speculative at best, in the absence of data estimating the intraovarian levels of these local regulators and the presence of their respective receptor/signal transduction systems.
The role of oestrogen in mediating inhibin production also requires consideration. The formation of the theca and the availability of androgen as substrate facilitates oestrogen production, which becomes significant in the ovary for the first time around day 10 (Carson & Smith 1986 ). This increase in oestrogen levels in vivo, may explain the decrease in A and B mRNA expression observed in ovaries of 12-day-old rats. This hypothesis was supported by our finding that DES treatment of immature rats down-regulated the expression of A and B subunit mRNA in granulosa cells, in the absence of any change in subunit expression. In contrast, Turner et al. (1989) using Northern blot analysis, reported that inhibin and A mRNA expression was increased by oestradiol treatment whereas B mRNA expression was uneffected. These granulosa cells were also isolated from DES-primed immature rats, but they were cultured in vitro for 48 h in the presence of oestradiol prior to the extraction of RNA. The absence of other endogenous regulators of inhibin subunit expression, perhaps those of thecal origin, in the in vitro environment may account for the differences observed between these studies. The impact of oestradiol treatment on inhibin subunit mRNA expression was also investigated by Aloi et al. (1995) using dot blot hybridisation. They found that a single injection of oestradiol to hypophysectomised rats led to increased expression of subunit but no change in the expression of either subunit by the ovary, 24 h after administration. The absence of gonadotrophins and the transient exposure to oestradiol employed in this model may have contributed to the findings of this report.
The 'altered' state of granulosa cells isolated from the ovaries of DES-treated immature rats has been highlighted in these and other reports (Drummond et al. 1999) . A recent study investigating the expression of oestrogen receptors (ER and ER ) in the ovary, reported that ER mRNAs were down-regulated in granulosa cells isolated from rat ovaries after DES treatment (Drummond et al. 1999) . Thus, researchers applying this model to studies of ovarian function, particularly those with an interest in inhibin/activin production or expression, should be aware that inhibin subunit expression is suppressed in these granulosa preparations. Additional studies are required to establish whether this suppression is reversed in culture.
In summary, it has been shown that (a) post-natal rat ovaries and isolated granulosa cells express all three inhibin subunit mRNAs. (b) Cultures of dispersed post-natal ovaries and granulosa cells produced inhibin-A, inhibin-B and -subunit. (c) subunit production generally exceeded that of both dimeric inhibins and was reflected in the increased expression of subunit mRNA relative to subunit mRNAs. (d) Both inhibin-A and inhibin-B were produced by day-4 post-natal ovaries containing only primordial and primary follicles but, with the appearance of secondary and antral follicles, inhibin-A production increased relative to that of inhibin-B. (e) The decline in inhibin subunit expression by the post-natal ovary may be explained in part by the production of oestrogen in situ by maturing follicles. (f ) FSH and TGF-plus FSH promoted dimeric inhibin-A production by day-8 post-natal ovaries which contain only primordial, primary and secondary preantral follicles, whereas TGF-alone did not alter the ratio of inhibin-A to subunit from that of controls. It is concluded that the profile of dimeric inhibin production by rat granulosa cells changes during folliculogenesis and that inhibin-A is the form produced by the differentiated ovary. Further definition of these profiles will require the availability of rat standards for each of the inhibins.
